BE FOREWARNED IF YOU ARE CHASING DIVIDENDS $TEVA $MYL $PRGO $RDY $ABX $MCK $CAH $ESRX

Twitter
LinkedIn
Facebook

 

PAY ATTENTION TO HOW CHASING DIVIDENDS JUST RUINED SOME INVESTORS $TEVA $MYL $PRGO $RDY $ABX $MCK $CAH $ESRX

Dividend-chasing is in vogue. Given low interest rates, many investors say they have no other choice.

Such thinking leads to costly mistakes. It just badly hurt those who had bought shares of Teva Pharmaceutical Industries TEVA,  because of its high dividend yield.

This isn’t just an issue for Teva investors, of course. There are many companies whose share price is being held up by dividend chasers. Take what happened in this case, however, as a reminder to review your portfolio and then sell those dividend-paying stocks where underlying businesses are deteriorating.

In the case of Teva, the warning signs were certainly there, but investors who were focused on the dividend missed them. Click here to see an annotated chart. The chart also shows the points when the “smart money” was selling into the strength generated by dividend chasers.

On the surface, the dividend yield looked attractive. Not only did the company pay a good dividend, but it was passing other screens that many investors use. These include the longevity of the dividend, dividend growth and the payout ratio, which is the share of net income that is paid in dividends. The chart shows the point when the dividend yield reached 4.5%.

But all wasn’t well at Teva, which is best known for its generic-drug business but also has a branded (or not generic) drugs unit. Prices on generic drugs have been under pressure, and its main branded drug, Copaxone, was facing patent challenges.

While Teva’s business showed signs of improvement at the end of 2016, that quickly disappeared, and it became clearer that competitors would succeed in a long-running patent battle over Copaxone, a treatment for multiple sclerosis…Read more at MarketWatch

You are receiving less than 2% of the content from our paid services …TO RECEIVE REMAINING 98%, TAKE A FREE TRIAL TO PAID SERVICES.

Please click here to take advantage of a FREE  30 day trial.

Check out our enviable performance in both bull and bear markets.

Subscribe to 'Generate Wealth'

Free Forever

More To Explore

30 Day Free Trial

Cancel within 30 days and you owe nothing

When you take a FREE 30 day trial, you get access to powerful techniques used by billionaires and hedge funds to grow richer. You can continue to use these powerful techniques to grow richer even if you cancel your subscription. You come out ahead by subscribing no matter how you look at it.

Do you want to gain an edge in the markets? Join thousands of your fellow investors and money managers to subscribe to Generate Wealth newsletter.

FREE FOREVER

Follow The Most Accurate Stock Market Analysis

Unrivaled Insights
In Bull and Bear Markets

Generate Wealth Newsletter
Free Forever

Generate Wealth Newsletter
Free Forever